US Patent Issued on Oct. 28 for "Personalized immunotherapy for rejuvenating activating and strengthening exhausted and dysfunctional T cells, reducing PD-1, and improving immune function" (Israeli Inventor)

ALEXANDRIA, Va., Oct. 28 -- United States Patent no. 12,455,279, issued on Oct. 28.

"Personalized immunotherapy for rejuvenating activating and strengthening exhausted and dysfunctional T cells, reducing PD-1, and improving immune function" was invented by Mia Levite (Savyon, Israel).

According to the abstract* released by the U.S. Patent & Trademark Office: "Methods of adoptive NeuroImmunotherapy, selecting a subject suitable for adoptive NeuroImmunotherapy, selecting a molecule or combination of molecules for improving therapeutic immune cell potential, and decreasing PD-1 expression on a surface of an immune cell, comprising contacting immune cells with at least one molecule selected from a neurotransmitter or analog thereof, a neurope...